DR. ABDULMASSIH ABDULMASSIH M.D. NPI 1629045778

NPI Details

DR. Abdulmassih Abdulmassih, M.D. is a family medicine in Chicago, IL with 46 years of experience. The provider is family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity. DR. Abdulmassih Abdulmassih, M.D. NPI is 1629045778. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

6201 W TOUHY AVE
CHICAGO, IL
ZIP 60646-100
Phone: (847) 673-5166
Fax: (847) 673-5636

The NPI 1629045778 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg (HCPCS:J7322)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Follow-up nursing facility visit per day, typically 25 minutes (HCPCS:99309)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Blood glucose (sugar) test performed by hand-held instrument (HCPCS:82962)
• Hemoglobin a1c level (HCPCS:83036)
• Automated urinalysis test (HCPCS:81003)
• Urine microalbumin (protein) analysis (HCPCS:82044)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Annual depression screening, 15 minutes (HCPCS:G0444)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a (HCPCS:G0179)
• Initial nursing facility visit per day, typically 45 minutes (HCPCS:99306)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Blood test, clotting time (HCPCS:85610)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid-19), influenza a, and influenza b) in upper respiratory specimen, each reported as detected or not detected (HCPCS:0240U)
• Removal of impacted ear wax (HCPCS:69210)
• Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and (HCPCS:G0180)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Pneumococcal vaccine, 13-valent (HCPCS:90670)
• Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Pneumococcal vaccine, 23-valent (HCPCS:90732)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Nursing facility discharge management, more than 30 minutes (HCPCS:99316)
• Injection of anesthetic agent and/or steroid into suprascapular shoulder nerve (HCPCS:64418)
• Hospital discharge day management, more than 30 minutes (HCPCS:99239)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Inhalation treatment for airway obstruction or sputum production (HCPCS:94640)
• Injection of anesthetic agent and/or steroid into lower back and leg nerve (HCPCS:64445)
• Evaluation of use of breathing device (HCPCS:94664)
• Influenza vaccine, quadrivalent, 0.5 ml dosage (HCPCS:90688)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• Test to measure expiratory airflow and volume changes before and after medication administration (HCPCS:94060)
• Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Hospital observation or inpatient care admitted and discharged on the same day for high severity problem, typically 55 minutes (HCPCS:99236)
• Varicose vein removal (HCPCS:NAN08)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 3/7/2006 and was last updated on 8/4/2015.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.